Stuttgart, Germany – August 6th, 2015 – Impulse Dynamics, announced today the first implantation of its Optimizer IVs device in Switzerland, continuing the global expansion of its innovative technology. The Optimizer IVs is a minimally invasive implantable device for treatment of Chronic Heart Failure (CHF). The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses to the heart. The implantation took place in Kantonspital Freiburg by Dr. Denis Graf.

Dr. Graf commented: “I am pleased to provide the Optimizer system to our patients, and specifically to those Chronic Heart Failure patients with Narrow QRS Complex that are not adequately controlled with pharmaceutical treatment alone and do not have any other device based therapy alternatives.“

“We are very pleased to be able to add Switzerland to the list of countries that offer the CCM therapy, delivered by the Optimizer device ” said Dr. Simos Kedikoglou, CEO of Impulse Dynamics. “CCM is a technology that meets a major need globally, and we are committed to expanding its introduction through healthcare systems worldwide to benefit more patients with heart failure”.